April 27 (Reuters) - Drugmaker Valeant Pharmaceuticals (NYSE:VRX)
International Inc VRX.TO is expected to name four new
directors as soon as Friday, the Wall Street Journal reported.
Five of its long-standing directors have agreed to step down
to make room for the new nominees, the Journal reported, citing
people familiar with the matter. (http://on.wsj.com/1rjdY27)
Valeant chairman Robert Ingram is also considering leaving,
the report said, citing a source.
New Chief Executive Joseph Papa, former Perrigo Co (NYSE:PRGO) Plc
PRGO.N head, will also join the board and take on the role of
chairman, the report said.